SCHEMBL3663783

SCHEMBL3663783

CCCCOC(=O)NCC(CC(=O)O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.64
SMN1; SMN2 Q16637 5/20 0.64
NPC1 O15118 5/20 0.64
LMNA P02545 2/20 0.64
POLB P06746 1/20 0.49
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
GABBR2 O75899 1/20 0.44
GABBR1 Q9UBS5 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 1/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2C9 P11712 1/20 0.42
CASP1 P29466 1/20 0.42
KMT2A Q03164 1/20 0.42
FNTA P49354 2/20 0.42
FNTB P49356 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6251493 0.88 RAB9A (0.63) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL5224263 0.87 SMN1; SMN2 (0.55) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL28335649 0.82 NPC1 (0.69) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL15738570 0.82 SMN1; SMN2 (0.92) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL11822749 0.81 SMN1; SMN2 (0.56) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL9468152 0.81 ALDH1A1 (0.50) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL11820462 0.79 NPC1 (0.60) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL844472 0.78 SMN1; SMN2 (0.57) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL14040614 0.78 SMN1; SMN2 (0.57) RAB9ASMN1; SMN2NPC1LMNAPOLB
SCHEMBL4583612 0.77 MAPT (0.54) MAPTGAAGABBR2GABBR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234982-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009080523-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-07-02 WO disclosed
EP-1989186-A1 HYDANTOIN BASED KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-12 EP disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed
WO-2007096259-A1 HYDANTOIN BASED KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-30 WO disclosed
EP-1781649-A2 SUBSTITUTED HYDANTOINS F. Hoffmann-Roche AG (CH) 2007-05-09 EP disclosed
WO-2006018188-A2 SUBSTITUTED HYDANTOINS F. HOFFMANN-LA ROCHE AG (CH) 2006-02-23 WO disclosed